In vitro evaluation of oxoplatin: An oral platinum(IV) anticancer agent

Metal-Based Drugs

Volumn 2009, Issue , 2009, Pages

  Hamilton, Gerhard ^a,b   Olszewski, Ulrike ^a,b   Ach, Florian ^a,b   Ulsperger, Ernst ^a   Baumgartner, Gerhard ^a   Zeillinger, Robert ^a   Bednarski, Patrick ^c  

^a Ludwig Boltzmann Cluster Translational Oncology   (Austria)

^b UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^c UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASCORBIC ACID; CIS AMMINEDICHLORO(CYCLOHEXYLAMINE)DIHYDROXOPLATINUM; CIS DIAMMINE TETRACHLORIDOPLATINUM; CISPLATIN; COMPLEMENTARY DNA; HYDROCHLORIC ACID; OXOPLATIN; PLATINUM AMMINE CYCLOHEXYLAMINE DICHLORIDE; PLATINUM DERIVATIVE; REACTIVE OXYGEN METABOLITE; RNA; SATRAPLATIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL DEATH; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CANCER; PRIORITY JOURNAL; STOMACH ACID;

EID: 68249159890     PISSN: 07930291     EISSN: None     Source Type: Journal    
DOI: 10.1155/2009/348916     Document Type: Article

References (42)

1. Rosenberg B., van Camp L., Krigas T., Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode Nature 1965 205 4972 698 699
2. Boulikas T., Vougiouka M., Cisplatin and platinum drugs at the molecular level Oncology Reports 2003 10 6 1663 1682
3. Rabik C. A., Dolan M. E., Molecular mechanisms of resistance and toxicity associated with platinating agents Cancer Treatment Reviews 2007 33 1 9 23
4. Kelland L., The resurgence of platinum-based cancer chemotherapy Nature Reviews Cancer 2007 7 8 573 584
5. aludov R., kovsk A., Kaprkov J., DNA interactions of bifunctional dinuclear platinum(II) antitumor agents European Journal of Biochemistry 1997 246 2 508 517
6. Kostova I., Platinum complexes as anticancer agents Recent Patents on Anti-Cancer Drug Discovery 2006 1 1 1 22
7. Ota K., Nedaplatin Japanese Journal of Cancer and Chemotherapy 1996 23 3 379 387
8. Weiss R. B., Christian M. C., New cisplatin analogues in development: a review Drugs 1993 46 3 360 377
9. Kelland L. R., McKeage M. J., New platinum agents. A comparison in ovarian cancer Drugs Aging 1994 5 2 85 95
10. Bednarski P. J., Mackay F. S., Sadler P. J., Photoactivatable platinum complexes Anti-Cancer Agents in Medicinal Chemistry 2007 7 1 75 93
11. Farrell N. P., Preclinical perspectives on the use of platinum compounds in cancer chemotherapy Seminars in Oncology 2004 31 supplement 14 1 9
12. Dolman R. C., Deacon G. B., Hambley T. W., Studies of the binding of a series of platinum(IV) complexes to plasma proteins Journal of Inorganic Biochemistry 2002 88 3-4 260 267
13. Hall M. D., Alderden R. A., Zhang M., The fate of platinum(II) and platinum(IV) anti-cancer agents in cancer cells and tumours Journal of Structural Biology 2006 155 1 38 44
14. Hall M. D., Mellor H. R., Callaghan R., Hambley T. W., Basis for design and development of platinum(IV) anticancer complexes Journal of Medicinal Chemistry 2007 50 15 3403 3411
15. Kelland L., Broadening the clinical use of platinum drug-based chemotherapy with new analogues: satraplatin and picoplatin Expert Opinion on Investigational Drugs 2007 16 7 1009 1021
16. Choy H., Park C., Yao M., Current status and future prospects for satraplatin, an oral platinum analogue Clinical Cancer Research 2008 14 6 1633 1638
17. Vetter C., Wagner C., Kaluderovi G. N., Paschke R., Steinborn D., Synthesis, characterization, and cytotoxicity of trimethylplatinum(IV) complexes with 2-thiocytosine and 1-methyl-2-thiocytosine ligands Inorganica Chimica Acta 2009 362 1 189 195
18. Kelly M. E., Dietrich A., Gmez-Ruiz S., Platinum(IV) metallacrown ethers: synthesis, structures, host properties and anticancer evaluation Organometallics 2008 27 19 4917 4927
19. Krajinovi B. B., Kaluderovi G. N., Steinborn D., Synthesis and in vitro antitumoral activity of novel O,O′ -di-2-alkyl-(S,S)-ethylenediamine- N,N′ -di-2-propanoate ligands and corresponding platinum(II/IV) complexes Journal of Inorganic Biochemistry 2008 102 4 892 900
20. Kaluderovi G. N., Schmidt H., Schwieger S., Platinum(IV) complexes with ethylenediamine- N,N′ -diacetate diester (R2edda) ligands: synthesis, characterization and in vitro antitumoral activity Inorganica Chimica Acta 2008 361 5 1395 1404
21. Pendyala L., Cowens J. W., Chheda G. B., Dutta S. P., Creaven P. J., Identification of cis -dichloro-bis-isopropylamine platinum(II) as a major metabolite of iproplatin in humans Cancer Research 1988 48 12 3533 3536
22. Novakova O., Vrana O., Kiseleva I., Brabec V., DNA interactions of antitumour platinum(IV) complexes European Journal of Biochemistry 1995 228 3 616 624
23. Anderson W. K., Quagliato D. A., Haugwitz R. D., Narayanan V. L., Wolpert-DeFilippes M. K., Synthesis, physical properties, and antitumor activity of tetraplatin and related tetrachloroplatinum(IV) stereoisomers of 1,2-diaminocyclohexane Cancer Treatment Reports 1986 70 8 997 1002
24. Eastman A., Glutathione-mediated activation of anticancer platinum(IV) complexes Biochemical Pharmacology 1987 36 23 4177 4178
25. Hall M. D., Hambley T. W., Platinum(IV) antitumour compounds: their bioinorganic chemistry Coordination Chemistry Reviews 2002 232 1-2 49 67
26. Presnov M. A., Konovalova A. L., Kozlov A. M., Brovtsyn V. K., Romanova L. F., The antitumor activity of oxoplatinum Neoplasma 1985 32 1 73 83
27. Konovalova A. L., Presnov M. A., Zheligovskaia N. N., Treshchalina E. M., Antitumor effect of complex compounds of tetravalent platinum Doklady Akademii Nauk SSSR 1977 234 1 223 226
28. Laznickova A., Semecky V., Laznicek M., Zubr V., Koksal J., Kvetina J., Effect of oxoplatinum and CBDCA on renal functions in rats Neoplasma 1989 36 2 161 169
29. Lobanova E. A., Pharmacokinetics of the antitumor drug oxoplatinum labeled with 191Pt Meditsinskaya Radiologiya 1985 30 5 75 78
30. Lobanova E. A., Singin A. S., Moldovanova L. K., Masko A. S., Pharmacokinetic research on oxoplatinum Vestnik Akademii meditsinskikh Nauk SSSR 1986 5 56 61
31. Blatter E. E., Vollano J. F., Krishnan B. S., Dabrowiak J. C., Interaction of the antitumor agents cis,cis,trans-PtIV (NH3)Cl2(OH)2 and cis,cis,trans-PtIV [(CH3)2CHNH2]2Cl2(OH)2 and their reduction products with PM2 DNA Biochemistry 1984 23 21 4817 4820
32. Choi S., Filotto C., Bisanzo M., Reduction and anticancer activity of platinum(IV) complexes Inorganic Chemistry 1998 37 10 2500 2504
33. Ellis L. T., Er H. M., Hambley T. W., The influence of the axial ligands of a series of platinum(IV) anti-cancer complexes on their reduction to platinum(II) and reaction with DNA Australian Journal of Chemistry 1995 48 4 793 806
34. Roat R. M., Reedijk J., Reaction of mer-trichloro(diethylenetriamine) platinum(IV) chloride, (mer -[Pt(dien) Cl3 ]Cl), with purine nucleosides and nucleotides results in formation of platinum(II) as well as platinum(IV) complexes Journal of Inorganic Biochemistry 1993 52 4 263 274
35. Scovell W. M., Muirhead N., Kroos L. R., cis - diamminedichloroplatinum(II) selectively cross-links high mobility group proteins 1 and 2 to DNA in micrococcal nuclease accessible regions of chromatin Biochemical and Biophysical Research Communications 1987 142 3 826 835
36. Toney J. H., Donahue B. A., Kellett P. J., Bruhn S. L., Essigmann J. M., Lippard S. J., Isolation of cDNAs encoding a human protein that binds selectively to DNA modified by the anticancer drug cis - diamminedichloroplatinum(II) Proceedings of the National Academy of Sciences of the United States of America 1989 86 21 8328 8332
37. Hughes E. N., Engelsberg B. N., Billings P. C., Purification of nuclear proteins that bind to cisplatin-damaged DNA. Identity with high mobility group proteins 1 and 2 The Journal of Biological Chemistry 1992 267 19 13520 13527
38. Chu G., Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair The Journal of Biological Chemistry 1994 269 2 787 790
39. Kratochwil N. A., Ivanov A. I., Patriarca M., Surprising reactions of iodo Pt(IV) and Pt(II) complexes with human albumin: detection of Cys34 sulfenic acid Journal of the American Chemical Society 1999 121 36 8193 8203
40. Neault J. F., Tajmir-Riahi H. A., Interaction of cisplatin with human serum albumin. Drug binding mode and protein secondary structure Biochimica et Biophysica Acta 1998 1384 1 153 159
41. Hall M. D., Amjadi S., Zhang M., Beale P. J., Hambley T. W., The mechanism of action of platinum(IV) complexes in ovarian cancer cell lines Journal of Inorganic Biochemistry 2004 98 10 1614 1624
42. Hambley T. W., Battle A. R., Deacon G. B., Modifying the properties of platinum(IV) complexes in order to increase biological effectiveness Journal of Inorganic Biochemistry 1999 77 1-2 3 12